Valerie Taylor
教授
Department of Psychiatry
Cumming School of Medicine, University of Calgary;University of Calgary and Alberta Health Services;Canadian Obesity Network – Réseau Canadien en Obésité;Alberta Health Services;Women’s College Research Institute, Women's College Hospital;Institute of Medical Science, University of Toronto
关注
立即认领
分享
关注
立即认领
分享
基本信息
浏览量:0
职业迁徙
个人简介
The research activities of the Taylor Lab are focused broadly on the area of the brain body interface. We are interested in both translational research examing now novel compounds impact psychiatric & illness.
A major focus is the gut brain axis and investigating how manipulation of this system can be used as a potential therapeutic target for new treatments and how psychiatric illness impacts the gut microbiome. We are currently running the only clinical trials in North America using fecal transplant to target mood disorders, and are running a longitudinal microbiome biobank which contains detailed clinical, fMRI, and biological (feces, urine, blood) data.
Preclinical research is done with partners within the HBI and Snyder institute. We also study the impact of medical comorbidities (obesity, diabetes and cardiovascular disease) on mental illness and conversely. The impact of mental illness of medical comorbity.
We are also engaged in a number of clinical trials looking at the impact of novel compounds on mental illness (fecal transplant, psilocybin).
The lab also partners with large research groups (CANBIND, IMAGINE) to engage in work aimed at improving our understanding of the brain body interface.
A major focus is the gut brain axis and investigating how manipulation of this system can be used as a potential therapeutic target for new treatments and how psychiatric illness impacts the gut microbiome. We are currently running the only clinical trials in North America using fecal transplant to target mood disorders, and are running a longitudinal microbiome biobank which contains detailed clinical, fMRI, and biological (feces, urine, blood) data.
Preclinical research is done with partners within the HBI and Snyder institute. We also study the impact of medical comorbidities (obesity, diabetes and cardiovascular disease) on mental illness and conversely. The impact of mental illness of medical comorbity.
We are also engaged in a number of clinical trials looking at the impact of novel compounds on mental illness (fecal transplant, psilocybin).
The lab also partners with large research groups (CANBIND, IMAGINE) to engage in work aimed at improving our understanding of the brain body interface.
研究兴趣
论文共 220 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Emma A. van Reekum, Michael Darcy, Jaslyn Drage, Joshua Xu, Kimberly Ng, Benjamin Forestell, Nancy Santesso,Raed Joundi,Jorge Wong,Aristithes Doumouras,Valerie H. Taylor,Salim Yusuf,
crossref(2024)
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIEpp.7067437241234954-7067437241234954, (2024)
BMC Primary Careno. 1 (2024): 1-12
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIEno. 3 (2024): 183-195
EXPERT OPINION ON PHARMACOTHERAPYno. 18 (2023): 1957-1961
JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRYno. 3 (2023)
引用0浏览0引用
0
0
Clinical pharmacology and therapeuticsno. 1 (2023): 88-117
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn